TRA-SCH-530348 -Oral Antiplatelet Agent
Key Data:
Drug (Brand/Generic)
TRA-SCH 530348
Company/Licensee
Schering-Plough
Therapy Class
Thrombin-receptor antagonist
Product Description
Blocks the platelet PAR-1 receptor to which thrombin binds
Current Indication
ACS
Market Sector
Cardiovascular
Development Status
Phase III
